Literature DB >> 8730311

High plasma levels of nitrogen oxides are associated with severe disease and correlate with rapid parasitological and clinical cure in Plasmodium falciparum malaria.

P G Kremsner1, S Winkler, E Wildling, J Prada, U Bienzle, W Graninger, A K Nüssler.   

Abstract

Plasma levels of nitrogen oxide (NO), neopterin and C-reactive protein (CRP) were compared in 3 groups of Gabonese patients with Plasmodium falciparum malaria before and after therapy: adults with uncomplicated malaria, children with uncomplicated malaria, and children with severe malaria. Plasma levels of all 3 molecules were significantly higher in severe malaria than in uncomplicated malaria. High levels of neopterin and CRP during the acute phase of malaria significantly correlated with slow parasitological and clinical cure after therapy. In contrast, high NO plasma levels during the acute phase of malaria predicted accelerated cure. These findings provide further evidence for the protective role of NO in malaria. However, as NO levels were highest in severe disease, overproduction may be harmful for the patients.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8730311     DOI: 10.1016/s0035-9203(96)90476-9

Source DB:  PubMed          Journal:  Trans R Soc Trop Med Hyg        ISSN: 0035-9203            Impact factor:   2.184


  26 in total

1.  Blood mononuclear cell nitric oxide production and plasma cytokine levels in healthy gabonese children with prior mild or severe malaria.

Authors:  D J Perkins; P G Kremsner; D Schmid; M A Misukonis; M A Kelly; J B Weinberg
Journal:  Infect Immun       Date:  1999-09       Impact factor: 3.441

2.  Nucleotide and haplotypic diversity of the NOS2A promoter region and its relationship to cerebral malaria.

Authors:  David Burgner; Stanley Usen; Kirk Rockett; Muminatou Jallow; Hans Ackerman; Alessandra Cervino; Margaret Pinder; Dominic P Kwiatkowski
Journal:  Hum Genet       Date:  2003-01-28       Impact factor: 4.132

3.  Mycobacterium-induced potentiation of type 1 immune responses and protection against malaria are host specific.

Authors:  Kathleen R Page; Anne E Jedlicka; Benjamin Fakheri; Gregory S Noland; Anup K Kesavan; Alan L Scott; Nirbhay Kumar; Yukari C Manabe
Journal:  Infect Immun       Date:  2005-12       Impact factor: 3.441

4.  Changes in cytokine production associated with acquired immunity to Plasmodium falciparum malaria.

Authors:  M S Rhee; B D Akanmori; M Waterfall; E M Riley
Journal:  Clin Exp Immunol       Date:  2001-12       Impact factor: 4.330

5.  Anti-adhesive effect of nitric oxide on Plasmodium falciparum cytoadherence under flow.

Authors:  Supattra Serirom; Wahaju H Raharjo; Kesinee Chotivanich; Sornchai Loareesuwan; Paul Kubes; May Ho
Journal:  Am J Pathol       Date:  2003-05       Impact factor: 4.307

Review 6.  Pathogenesis of malaria and clinically similar conditions.

Authors:  Ian A Clark; Lisa M Alleva; Alison C Mills; William B Cowden
Journal:  Clin Microbiol Rev       Date:  2004-07       Impact factor: 26.132

7.  Elevated nitric oxide production in children with malarial anemia: hemozoin-induced nitric oxide synthase type 2 transcripts and nitric oxide in blood mononuclear cells.

Authors:  Christopher C Keller; Peter G Kremsner; James B Hittner; Mary A Misukonis; J Brice Weinberg; Douglas J Perkins
Journal:  Infect Immun       Date:  2004-08       Impact factor: 3.441

8.  Cellular tumor necrosis factor, gamma interferon, and interleukin-6 responses as correlates of immunity and risk of clinical Plasmodium falciparum malaria in children from Papua New Guinea.

Authors:  Leanne J Robinson; Marthe C D'Ombrain; Danielle I Stanisic; Jack Taraika; Nicholas Bernard; Jack S Richards; James G Beeson; Livingstone Tavul; Pascal Michon; Ivo Mueller; Louis Schofield
Journal:  Infect Immun       Date:  2009-04-20       Impact factor: 3.441

9.  Circulating concentrations of soluble granzyme A and B increase during natural and experimental Plasmodium falciparum infections.

Authors:  C C Hermsen; Y Konijnenberg; L Mulder; C Loé; M van Deuren; J W M van der Meer; G J van Mierlo; W M C Eling; C E Hack; R W Sauerwein
Journal:  Clin Exp Immunol       Date:  2003-06       Impact factor: 4.330

Review 10.  C-reactive protein and the biology of disease.

Authors:  Waliza Ansar; Shyamasree Ghosh
Journal:  Immunol Res       Date:  2013-05       Impact factor: 2.829

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.